Category Archives: Company news

Join us for the most interactive biopharma event of the year!

Join us for the most interactive biopharma event of the year! 15th-17th October Royal Marine Hotel, Dublin Language: English The Waters European Biopharma Analytical Forum provides a unique opportunity to meet other biopharma experts across Europe, discuss your challenges and share your experience. It is an interactive and collaborative event but also an occasion to discover the latest innovations in…

Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists

In Vitro Diagnostic Device Designed for Dried Blood Spot Analysis Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists October 10, 2018 08:00 AM Eastern Daylight Time MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots…

The Historical Role of Mass Spectrometry in Newborn Screening

From the Guthrie Test to a unique technology collaboration Newborn screening for inherited metabolic disorders dates to the early 1960s, when Dr. Robert Guthrie in Buffalo, New York developed the first screening test for phenylketonuria (or PKU), a metabolic disease in which patients can’t metabolize the amino acid phenylalanine. The so-called “Guthrie Test” was simple,…


In 2015 the European Food Safety Authority published a risk assessment for Acrylamide in food. The assessment confirmed previous findings that acrylamide levels found in food could increase the risk of cancer for consumers. So far, there are no maximum levels in Europe for acrylamide in food. EU regulation 2017/2158, which came into force in April 2018,…

Food safety analysis using QuEChERS, LC-MS/MS and GC-MS/MS

Separation Science, in collaboration with Waters, offers a selection of presentations and resources demonstrating effective methods for food safety analysis using QuEChERS, LC-MS/MS and GC-MS/MS. The benefits of using the Xevo TQ-GC and Xevo TQ-S Miro in such applications is shown. View the presentations from the two experts below and download the resources to see…

Introducing Illumina Ampliseq On-demand custom panels

Create amplicon panels with the genes you want. AmpliSeq for Illumina On Demand panels provide a choice of > 5000 pretested genes with known content relevant for inherited disease research, including hereditary cancer, primary immunodeficiency, hearing loss, and muscular dystrophy. AmpliSeq chemistry and Illumina next-generation sequencing (NGS) technology provide unmatched data quality, even from low-quality…

Detectors for HPLC/UHPLC Systems

Waters enables you to analyze a wide variety of compounds by offering a large portfolio of detection technologies.  These detectors have a number of options, including flow cells and nebulizers, to match your separation scale and help you to achieve the goals of your analysis.  Our detection technologies are synonymous with sensitivity, stability and usability,…

The Illumina Day in Kyiv

  • IMG_0023 small
  • IMG_0058 small
  • IMG_0092 small
  • IMG_0388 small
  • IMG_0402 small
  • IMG_0408 small
  • IMG_0440 small
  • IMG_0446 small
  • IMG_0450 small
  • IMG_0466 small
  • IMG_0480 small
  • IMG_0531 small
  • IMG_0534 small
  • IMG_0574 small
  • IMG_0587 small
  • IMG_0604 small
  • IMG_0621 small
  • IMG_0633 small
  • IMG_0688 small
  • IMG_0701 small
  • IMG_0742 small
  • IMG_0813 small
  • IMG_0828 small
  • IMG_0835 pan small
  • IMG_0867 small
  • IMG_0894 small
  • IMG_0932 small
  • IMG_0952 small
  • IMG_0976 small
  • IMG_1010 small
  • IMG_1013 small
  • IMG_1034 small
  • IMG_1048 small
  • IMG_1051 small
  • IMG_8897 small
  • IMG_8904 small
  • IMG_8924 small

The Illumina Day in Kyiv was defintely a no. 1 event in the Ukrainian genomic community for the first half of 2018 at least. The goal was not only to increase the awareness about Illumina products and solutions but also help researchers and practitioners to fill gaps between basic and applied segments. We are fascinated that Ukrainian NGS community is developing around Illumina as the world's largest provider of NGS-relevant products. Most of visitors are still new to NGS, and now they can see that NGS doible, affordable and efficient. Not less important, people saw that Illumina is already here, in Ukraine, through its channel partner, IMG, ready to offer all kinds of support and help building NGS labs from ground zero. This has assured many potential customers that they won't be let alone with their instruments in case of trouble.

The main focus of the Illumina Day in Kyiv was genetic counceling (exome panels) and oncology (target panels). Yet people from many other areas, such as horticulture and agrigenomics, found a lot of useful information. And of course, reproductive geneticists and basic researchers - NGS pioneers in Ukraine - were very active in dicussions and seminars.

From Illumina side, there were presentations by:
Florian Graedler
Sr. Product Specialist Distributors EMEA
Illumina Germany GmbH.

Anton Tsiganov-Boudunov, Bioinformatics Implementation & Support Lead
Staff Bioinformatics Support Scientist
Illumina UK Ltd.

Holly Zheng Bradley
Staff Bioinformatics Scientist
Bioinformatics & Professional Services
illumina UK Ltd.

Yakov Vitrenko,
Scientific consultant for Illumina sequencing applications,
IMG, Ukraine.

The second half of the plenary day was reserved for Illumina users delivering success stories. The keynote speaker was Rafal Ploski, Warsaw Medical University, whose expertise in whole exome sequencing for the diagnostics of rare undiagnosed genetic diseases is widely acclaimed.

On the second day, we held three seminars for a smaller group focusing on for library prep, lab set-up and bioinformatics. Participants had a chance to see the advantages of using BaseSpace for their data processing pipelines, got insight into the sequencing routine and ways of optimizing an NGS lab.

The event was definitely very efficient from the buisness perspective as well. At least five leads were created and the existing opportunities have got accelerated.

The overall feedback was very favorable and we dare to conclude that we accomplished our goals. People enjoyed not only the format but the location: UNIT center, an innovation park offering platform for all kinds of IT and biotech start-ups. Holding the Illuimina day at such "futuristic" young smarties-oriented place rather than a traditional academic institute proved to be the right choice.

Now IMG has guite a long list of new connections and proposals to sort out and is looking towards a larger expansion in the Ukrainian market.